VelosBio Finds $137M For Oncology Efforts
socalTECH
JULY 8, 2020
San Diego-based biopharmaceuticals developer VelosBio says it has raised $137M in a Series B funding roudn, to go towards its oncology efforts. Rowe Price Associates, Inc., Venrock Healthcare Capital Partners, Viking Global Investors, Wellington Management Company, as well as the company's existing investors.
Let's personalize your content